
Mallinckrodt and Endo Announce Merger: Creating a Global Pharmaceutical Leader with Diversified Portfolio
Two Leading Pharmaceutical Companies Announce Strategic Combination DUBLIN and MALVERN, Pa., [Date] – Two prominent players in the pharmaceutical industry, CompanyA and CompanyB, have announced a strategic combination to broaden patient access and develop new therapies to address unmet patient needs. This transaction brings together two highly complementary businesses, each with a heavily U.S.-focused footprint…